Resources tagged with "fda"

Gore Receives FDA Clearance for GORE® SYNECOR Preperitoneal Biomaterial Hernia Repair Device

Hybrid of unique bioabsorbable and permanent materials provide a single-stage hernia repair to help minimize complications in preperitoneal applications

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Provides Improved Outcomes in Real-World Peripheral Arterial Disease Cases

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval

Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms

Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis

Longest stent-graft introduced in the United States

First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study

Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population

Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft

Results of early cannulation clinical trial presented at the 2013 VEITHsymposium

Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection

Conformable GORE® TAG® Thoracic Endoprosthesis First to Receive Indication for Aneurysm, Trauma and Dissection

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

Device designed to bring endovascular therapy options to patients previously considered untreatable

Gore Receives FDA Approval for New GORE® EXCLUDER® AAA Endoprosthesis Components

Expanded Treatment Options for Abdominal Aortic Aneurysms Provide More Patients with Access to Minimally Invasive Endovascular Repair

First Patient Enrolled in GORE® TAG® Thoracic Branch Endoprosthesis Early Feasibility Study

First Early Feasibility Study of a Gore Device Will Assess Treatment of Aortic Arch Aneurysms